Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Security class unavailable · CUSIP: 75382E109

Event date: 2020-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,628,020
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-20-001676
Form type
SC 13G/A
Filer
PRICE T ROWE ASSOCIATES INC /MD/
CIK
CIK 80255
Filed
Oct 13, 2020
Reporting period
Sep 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub